JAK inhibitors attenuate hyperactivation of nonswitched memory B cells in rheumatoid arthritis patients in remission

Table 3 Correlation analysis of B cells subsets, activation markers on NSMB cells and clinical manifestations

clinical manifestations	SMB(%)		NSMB (%)		DNB (%)		NAVB(%)		CD80+ on NSMB(%)		CD95+ on NSMB(%)		CD21^low on NSMB(%)
clinical manifestations	r	p	r	p	r	p	r	p	r	p	r	p	r	p
DAS28-ESR	-0.190	0.072	-0.254*	0.018	-0.149	0.161	0.231*	0.027	0.255*	0.037	0.163	0.189	0.086	0.490
ESR	-0.247*	0.025	-0.182	0.084	0.148	0.183	0.283*	0.009	0.258*	0.048	0.275*	0.035	0.192	0.145
h-CRP	-0.218	0.053	-0.042	0.714	-0.199	0.077	0.216	0.054	0.177	0.150	0.094	0.447	0.029	0.816
CCP	0.079	0.490	-0.120	0.294	-0.018	0.875	0.026	0.822	-0.045	0.716	-0.091	0.460	-0.003	0.978
RF	0.010	0.929	-0.077	0.508	-0.109	0.350	0.050	0.669	0.113	0.358	0.008	0.950	-0.082	0.509
IgG	-0.109	0.059	-0.209*	0.049	-0.115	0.285	0.232*	0.029	-0.060	0.615	0.256*	0.030	0.009	0.937
IgM	0.166	0.121	0.187	0.079	0.036	0.740	-0.189	0.076	-0.038	0.753	0.101	0.398	-0.051	0.673
IgA	-0.196	0.068	-0.356*	0.012	0.034	0.751	0.158	0.130	-0.016	0.895	0.069	0.566	0.256*	0.030

ISSN: 1478-6362